<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03584282</url>
  </required_header>
  <id_info>
    <org_study_id>STUDY00004760</org_study_id>
    <secondary_id>1R34DA045620-01</secondary_id>
    <nct_id>NCT03584282</nct_id>
  </id_info>
  <brief_title>Interventions to Improve the HIV PrEP Cascade Among Methamphetamine Users</brief_title>
  <official_title>Interventions to Improve the HIV PrEP Cascade Among Methamphetamine Users</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Washington</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Institute on Drug Abuse (NIDA)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Washington</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Despite increasing knowledge about and use of PrEP nationally, HIV continues to have
      disproportionate impact among cisgender men and transgender persons who have sex with men and
      transgender persons (MSM/TG), with methamphetamine (meth)-users being at particularly high
      risk. Building on their preliminary work, the investigators will pilot text messaging and
      peer navigation interventions to support PrEP use among meth-using MSM/TG with potential to
      be cost-effective, scalable, and easily adaptable.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Despite increasing knowledge about and use of PrEP nationally, HIV continues to have
      disproportionate impact among cisgender men and transgender persons who have sex with men and
      transgender persons (MSM/TG), with methamphetamine (meth)-users being at particularly high
      risk. Despite apparent high levels of PrEP knowledge and exceptional insurance and medication
      coverage, few meth-users in Western WA have enrolled in local PrEP programs. The
      investigators' preliminary work with meth-using MSM/TG has identified both traditional
      barriers to PrEP and barriers specific for meth users, including competing priorities (e.g.,
      getting high); lack of regularity in daily schedules leading to difficulties complying with
      appointments and medication adherence; and concomitant wellness and social concerns, notably
      depression and meth-related stigma. Additional work is needed to develop new strategies to
      increase PrEP uptake and support persistence and adherence among meth-using MSM/TG. Building
      on their preliminary work, the investigators will pilot text messaging and peer navigation
      interventions to support PrEP use among meth-using MSM/TG with potential to be
      cost-effective, scalable, and easily adaptable. The first, peer navigation, has been studied
      in ARV treatment and has been proposed for PrEP. The second, text messaging, has been shown
      to increase ARV and PrEP adherence.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date type="Actual">July 11, 2018</start_date>
  <completion_date type="Anticipated">June 18, 2020</completion_date>
  <primary_completion_date type="Anticipated">June 18, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Factorial Assignment</intervention_model>
    <intervention_model_description>The investigators will randomly assign 10 participants to each arm: 1) standard of care, 2) text messaging only, 3) peer navigation only, and 4) text messaging and peer navigation.</intervention_model_description>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Acceptability of text messaging intervention</measure>
    <time_frame>6 months</time_frame>
    <description>Self-reported acceptability via surveys and interviews</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Acceptability and impact of text messaging intervention.</measure>
    <time_frame>6 months</time_frame>
    <description>Self-reported acceptability via surveys and interviews</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>PrEP persistence</measure>
    <time_frame>6 months</time_frame>
    <description>Persistence on PrEP comparing standard of care vs text messaging vs peer navigation vs both interventions.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>PrEP adherence</measure>
    <time_frame>6 months</time_frame>
    <description>PrEP adherence measured in dried blood spots comparing standard of care vs text messaging vs peer navigation vs both interventions.</description>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Anticipated">40</enrollment>
  <condition>HIV/AIDS</condition>
  <condition>Adherence, Medication</condition>
  <condition>Drug Use</condition>
  <arm_group>
    <arm_group_label>Standard of Care</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Participants in this group will receive the standard of care for PrEP follow-up and no additional research interventions.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Text Messaging</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Participants in this group will receive the text messaging intervention.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Peer Navigation</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Participants in this group will receive the peer navigator intervention.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Text Messaging and Peer Navigation</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Participants in this group will receive both the text messaging and peer navigation interventions.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Text Messaging</intervention_name>
    <description>The text messaging intervention will send three text messages per day from a library. One will be a reminder to take PrEP, one will include PrEP information, and the third will have the content of the participant's choosing from categories of harm reduction messages and health information. Participants will also select the time period to receive these texts.</description>
    <arm_group_label>Text Messaging</arm_group_label>
    <arm_group_label>Text Messaging and Peer Navigation</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Peer Navigation</intervention_name>
    <description>The peer navigation intervention will provide support from a peer that is responsive to a participant's individualized needs. Peer support may include phone call reminders, help refilling PrEP prescriptions, transit assistance, or other referrals.</description>
    <arm_group_label>Peer Navigation</arm_group_label>
    <arm_group_label>Text Messaging and Peer Navigation</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Meets the clinic's eligibility criteria for PrEP

          -  18 years of age or older

          -  HIV-negative

          -  Cisgender man or individual on the trans gender variant spectrum who has sex with men

          -  Ability to understand, read, and speak English

          -  Reports meth use in the past 3 months

          -  Has a cell phone able to send and receive text messages

        Exclusion Criteria:

          -  PrEP use in the prior month,

          -  Discomfort or anxiety with regards to text messaging.

          -  Has any circumstances that, based on the study staff's opinion, would preclude
             provision of informed consent, make participation unsafe, or make it unlikely the
             participant would be able to participate for 6 months.
      </textblock>
    </criteria>
    <gender>All</gender>
    <gender_based>Yes</gender_based>
    <gender_description>cisgender men, transgender women, transgender men, and genderqueer individuals</gender_description>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Joanne Stekler, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Washington</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Vanessa M McMahan</last_name>
    <phone>206-616-5234</phone>
    <email>vmcmahan@uw.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>Kelley-Ross One-Step PrEP</name>
      <address>
        <city>Seattle</city>
        <state>Washington</state>
        <zip>98104</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Elyse Tung</last_name>
      <phone>206-324-6990</phone>
      <email>prep@kelley-ross.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Gay City</name>
      <address>
        <city>Seattle</city>
        <state>Washington</state>
        <zip>98122</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Luis Viquez</last_name>
      <phone>206-860-6969</phone>
      <email>prep@gaycity.org</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Mera R, McCallister S, Palmer B, Mayer G, Magnuson D, Rawlings K. Truvada (TVD) for HIV pre-exposure prophylaxis (PrEP) utilization in the United States (2013-2015). 21st International AIDS Conference; Durban, South Africa; July 18-22, 2016 [abstract TUAX0105LB]. In.</citation>
  </reference>
  <reference>
    <citation>Hood JE, Buskin SE, Dombrowski JC, Kern DA, Barash EA, Katz DA, Golden MR. Dramatic increase in preexposure prophylaxis use among MSM in Washington state. AIDS. 2016 Jan 28;30(3):515-9. doi: 10.1097/QAD.0000000000000937. Erratum in: AIDS. 2016 Jun 19;30(10 ):1689.</citation>
    <PMID>26562845</PMID>
  </reference>
  <reference>
    <citation>Beyrer C, Baral SD, van Griensven F, Goodreau SM, Chariyalertsak S, Wirtz AL, Brookmeyer R. Global epidemiology of HIV infection in men who have sex with men. Lancet. 2012 Jul 28;380(9839):367-77. doi: 10.1016/S0140-6736(12)60821-6. Epub 2012 Jul 20. Review.</citation>
    <PMID>22819660</PMID>
  </reference>
  <reference>
    <citation>Pitasi M, Llata E, Stenger M, Kerani R, Kohn R, Murphy R, et al. HIV prevalence among transgender women and men: results from the STD Surveillance Network, 2010-2013. 2015 National HIV Prevention Conference; Atlanta, GA; December 6-9, 2015 [abstract #1193]. In.</citation>
  </reference>
  <reference>
    <citation>Habarta N, Wang G, Mulatu MS, Larish N. HIV Testing by Transgender Status at Centers for Disease Control and Prevention-Funded Sites in the United States, Puerto Rico, and US Virgin Islands, 2009-2011. Am J Public Health. 2015 Sep;105(9):1917-25. doi: 10.2105/AJPH.2015.302659. Epub 2015 Jul 16.</citation>
    <PMID>26180964</PMID>
  </reference>
  <reference>
    <citation>Buskin S, Hood J, Katz DA. Estimating the population-level impact of methamphetamine use on HIV acquisition among men who have sex with men using population attributable risk percent - a powerful and underused planning tool. International AIDS Society Conference 2015. July 19-22, 2015. Vancouver. Abstract MOPEC491. In.</citation>
  </reference>
  <reference>
    <citation>McMahan V, Martin A, Garske L, Baeten JM, Banta-Green C, Stekler J. Knowledge about PrEP among MSM and Trans* Methamphetamine Users in Seattle. 24th Conference on Retroviruses and Opportunistic Infections; Seattle, WA; February 13-16, 2017 [#2063]. In.</citation>
  </reference>
  <reference>
    <citation>Simoni JM, Huh D, Frick PA, Pearson CR, Andrasik MP, Dunbar PJ, Hooton TM. Peer support and pager messaging to promote antiretroviral modifying therapy in Seattle: a randomized controlled trial. J Acquir Immune Defic Syndr. 2009 Dec 1;52(4):465-473.</citation>
    <PMID>19911481</PMID>
  </reference>
  <reference>
    <citation>Lester RT, Ritvo P, Mills EJ, Kariri A, Karanja S, Chung MH, Jack W, Habyarimana J, Sadatsafavi M, Najafzadeh M, Marra CA, Estambale B, Ngugi E, Ball TB, Thabane L, Gelmon LJ, Kimani J, Ackers M, Plummer FA. Effects of a mobile phone short message service on antiretroviral treatment adherence in Kenya (WelTel Kenya1): a randomised trial. Lancet. 2010 Nov 27;376(9755):1838-45. doi: 10.1016/S0140-6736(10)61997-6. Epub 2010 Nov 9.</citation>
    <PMID>21071074</PMID>
  </reference>
  <reference>
    <citation>Dowshen N, Kuhns LM, Johnson A, Holoyda BJ, Garofalo R. Improving adherence to antiretroviral therapy for youth living with HIV/AIDS: a pilot study using personalized, interactive, daily text message reminders. J Med Internet Res. 2012 Apr 5;14(2):e51. doi: 10.2196/jmir.2015.</citation>
    <PMID>22481246</PMID>
  </reference>
  <reference>
    <citation>Finitsis DJ, Pellowski JA, Johnson BT. Text message intervention designs to promote adherence to antiretroviral therapy (ART): a meta-analysis of randomized controlled trials. PLoS One. 2014 Feb 5;9(2):e88166. doi: 10.1371/journal.pone.0088166. eCollection 2014.</citation>
    <PMID>24505411</PMID>
  </reference>
  <reference>
    <citation>Liu A, Stojanovski K, Lester R. Developing and Implementing a Mobile Health (mHealth) Adherence Support System for HIV- Uninfected Men who have Sex with Men (MSM) Taking Pre-Exposure Prophylaxis (PrEP): The iText Study. 8th International Conference on HIV Treatment and Prevention Adherence; Miami, FL; June 2-4, 2013 [Abstract #165]. In.</citation>
  </reference>
  <verification_date>July 2018</verification_date>
  <study_first_submitted>June 19, 2018</study_first_submitted>
  <study_first_submitted_qc>July 11, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">July 12, 2018</study_first_posted>
  <last_update_submitted>July 11, 2018</last_update_submitted>
  <last_update_submitted_qc>July 11, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">July 12, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Washington</investigator_affiliation>
    <investigator_full_name>Joanne Stekler</investigator_full_name>
    <investigator_title>Associate Professor, School of Medicine: Allergy and Infectious Diseases</investigator_title>
  </responsible_party>
  <keyword>Pre-Exposure Prophylaxis (PrEP)</keyword>
  <keyword>Methamphetamine</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Acquired Immunodeficiency Syndrome</mesh_term>
    <mesh_term>HIV Infections</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

